6066 studies found for:    "Kidney Diseases"
Show Display Options
Rank Status Study
21 Terminated
Has Results
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease
Conditions: Anemia;   Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: Darbepoetin Alfa;   Drug: Placebo
22 Completed START: Sensipar Treatment Algorithm to Reach K/DOQI Targets in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism
Conditions: Kidney Disease;   Secondary Hyperparathyroidism;   Chronic Kidney Disease
Intervention: Drug: Sensipar
23 Completed Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Other: Standard
24 Terminated Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Sirolimus;   Drug: conventional therapy
25 Active, not recruiting Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency
Condition: Autosomal Dominant Polycystic Kidney Disease.
Interventions: Drug: Octreotide-LAR;   Other: Saline solution.
26 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
27 Enrolling by invitation Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tolvaptan (OPC-41061)
28 Unknown  Primary Cardiovascular Risk Prevention With Aspirin in Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 3
Intervention: Drug: Aspirin
29 Completed
Has Results
Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Placebo;   Drug: Everolimus
30 Completed Chronic Kidney Disease Prevention of An-Lo District, Keelung
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Death
Intervention: Behavioral: multidisciplinary predialysis education
31 Enrolling by invitation Effects of an Exercise Program in Patients With Hypertensive Chronic Kidney Disease
Conditions: Cardiovascular Disease;   Chronic Kidney Disease;   Chronic Renal Disease;   Hypertension
Intervention: Behavioral: exercise aerobic
32 Enrolling by invitation Open Label Extension Study for the Long-term Efficacy and Safety of FG-4592 in Dialysis and Non-dialysis Chronic Kidney Disease Patients
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Anemia
Intervention: Drug: FG-4592
33 Completed Efficacy of N-Acetylcysteine in Prevention of Post-Catheterization Contrast-Induced Nephropathy in Diabetic Patients With Chronic Kidney Disease
Conditions: Radiocontrast-Induced Nephropathy;   Chronic Kidney Disease;   Diabetes Mellitus
Interventions: Drug: N-acetylcysteine;   Drug: Placebo
34 Unknown  Improving Evidence-Based Primary Care for Chronic Kidney Disease
Conditions: Chronic Kidney Disease;   Chronic Kidney Insufficiency;   Chronic Renal Diseases;   Chronic Renal Insufficiency;   Kidney Insufficiency, Chronic
Interventions: Other: Facilitated Clinical Decision Support;   Other: Clinical Decision Support Only
35 Completed Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
Conditions: End-Stage Renal Disease;   Stage 5 Chronic Kidney Disease
Interventions: Drug: Telavancin;   Procedure: Pharmacokinetic Blood Sampling
36 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
37 Completed Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia
Conditions: End Stage Renal Disease;   Chronic Kidney Disease;   Hyperphosphatemic;   Kidney Disease
Interventions: Drug: AMG 223;   Drug: Placebo
38 Terminated Pyridorin in Diabetic Nephropathy
Conditions: Diabetic Nephropathy;   Diabetic Kidney Disease
Interventions: Drug: Pyridorin;   Drug: Placebo
39 Terminated
Has Results
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Conditions: Proteinuric Kidney Disease;   Diabetic Nephropathy;   Hypertensive Nephrosclerosis;   IgA Nephropathy;   Focal Segmental Glomerulosclerosis;   Glomerulopathy (Obesity-associated);   Glomerulonephritis, Membranous
Interventions: Drug: Aliskiren;   Drug: Valsartan
40 Completed Kidney Disease Biomarkers
Conditions: Kidney Disease;   Glomerular Disease;   Idiopathic Nephrotic Syndrome;   Focal Segmental Glomerulosclerosis;   Collapsing Glomerulopathy
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years